SOW
FULC icon

State of Wyoming’s Fulcrum Therapeutics FULC Stock Holding History

State of Wyoming’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.9K Buy
+1,815
New +$16.8K ﹤0.01% 1704
2022
Q1 		– Sell
-749
Closed -$13K – 1870
2021
Q4 		$13K Buy
+749
New +$14.8K 0.01% 1633

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

State of Wyoming's FULC Position: Q1 2026 in Review

State of Wyoming opened a new position in Fulcrum Therapeutics (FULC) in Q1 2026: 1,815 shares worth $13.9K. The stake represents ﹤0.01% of the portfolio and ranks #1704 among its holdings. This is a return to the name: State of Wyoming previously reported a position in FULC as recently as Q4 2021.

State of Wyoming first reported a position in FULC in Q4 2021 and has held it in 2 quarters since. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • State of Wyoming held 1,815 shares of Fulcrum Therapeutics worth $13.9K as of Q1 2026.
  • Fulcrum Therapeutics was a new State of Wyoming position in Q1 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of State of Wyoming's portfolio in Q1 2026, its #1704 holding.
  • State of Wyoming first reported a position in Fulcrum Therapeutics in Q4 2021 and has held it in 2 quarters since.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.